These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14593034)

  • 1. Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002.
    Chalmers I; Rounding C; Lock K
    BMJ; 2003 Nov; 327(7422):1017. PubMed ID: 14593034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Registration of noncommercial randomised clinical trials: the feasibility of using trial registries to monitor the number of trials.
    Raftery J; Fairbank E; Douet L; Dent L; Price A; Milne R; Walley T
    Trials; 2012 Aug; 13():140. PubMed ID: 22906196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reinvestigation of recruitment to randomised, controlled, multicenter trials: a review of trials funded by two UK funding agencies.
    Sully BG; Julious SA; Nicholl J
    Trials; 2013 Jun; 14():166. PubMed ID: 23758961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between funding by commercial interests and study outcome in randomized controlled drug trials.
    Yaphe J; Edman R; Knishkowy B; Herman J
    Fam Pract; 2001 Dec; 18(6):565-8. PubMed ID: 11739337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budgeting of non-commercial clinical trials: development of a budget tool by a public funding agency.
    Nevens H; Harrison J; Vrijens F; Verleye L; Stocquart N; Marynen E; Hulstaert F
    Trials; 2019 Dec; 20(1):714. PubMed ID: 31829233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origin and funding of the most frequently cited papers in medicine: database analysis.
    Patsopoulos NA; Ioannidis JP; Analatos AA
    BMJ; 2006 May; 332(7549):1061-4. PubMed ID: 16547014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The uncertainty principle and industry-sponsored research.
    Djulbegovic B; Lacevic M; Cantor A; Fields KK; Bennett CL; Adams JR; Kuderer NM; Lyman GH
    Lancet; 2000 Aug; 356(9230):635-8. PubMed ID: 10968436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005.
    Zwierzyna M; Davies M; Hingorani AD; Hunter J
    BMJ; 2018 Jun; 361():k2130. PubMed ID: 29875212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The funding market for nursing research.
    Salter B
    J Adv Nurs; 1985 Mar; 10(2):155-63. PubMed ID: 3845941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to register randomised trials.
    Horton R; Smith R
    Lancet; 1999 Oct; 354(9185):1138-9. PubMed ID: 10513702
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristics of funding of clinical trials: cross-sectional survey and proposed guidance.
    Hakoum MB; Jouni N; Abou-Jaoude EA; Hasbani DJ; Abou-Jaoude EA; Lopes LC; Khaldieh M; Hammoud MZ; Al-Gibbawi M; Anouti S; Guyatt G; Akl EA
    BMJ Open; 2017 Oct; 7(10):e015997. PubMed ID: 28982811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data monitoring in randomized controlled trials: surveys of recent practice and policies.
    Clemens F; Elbourne D; Darbyshire J; Pocock S;
    Clin Trials; 2005; 2(1):22-33. PubMed ID: 16279576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the scientific quality of publicly and privately funded randomized controlled drug trials.
    Jones R; Younie S; Macallister A; Thornton J
    J Eval Clin Pract; 2010 Dec; 16(6):1322-5. PubMed ID: 20738476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research funding.
    Warlow C; Sandercock P; Dennis M; Wardlaw J
    Lancet; 1999 Jun; 353(9171):2250. PubMed ID: 10393024
    [No Abstract]   [Full Text] [Related]  

  • 15. Health services research in the United Kingdom 1990-1992.
    Dowie R
    J Public Health Med; 1995 Mar; 17(1):93-7. PubMed ID: 7786576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Describing qualitative research undertaken with randomised controlled trials in grant proposals: a documentary analysis.
    Drabble SJ; O'Cathain A; Thomas KJ; Rudolph A; Hewison J
    BMC Med Res Methodol; 2014 Feb; 14():24. PubMed ID: 24533771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory barriers to academically funded randomised controlled trials involving medicines.
    Cauldwell M; Steer PJ
    BJOG; 2015 Oct; 122(11):1568. PubMed ID: 26406261
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trials for tomorrow funded by the MRC.
    Warlow C
    BMJ; 2003 Aug; 327(7409):240-1. PubMed ID: 12896912
    [No Abstract]   [Full Text] [Related]  

  • 19. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor.
    Flacco ME; Manzoli L; Boccia S; Capasso L; Aleksovska K; Rosso A; Scaioli G; De Vito C; Siliquini R; Villari P; Ioannidis JP
    J Clin Epidemiol; 2015 Jul; 68(7):811-20. PubMed ID: 25748073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.